CAS 11114-20-8|Carrageenan
| Common Name | Carrageenan | ||
|---|---|---|---|
| CAS Number | 11114-20-8 | Molecular Weight | 788.65800 |
| Density | / | Boiling Point | / |
| Molecular Formula | C24H36O25S2-- | Melting Point | / |
| MSDS | ChineseUSA | Flash Point | / |
Names
| Name | κ-carrageenan |
|---|
Carrageenan BiologicalActivity
| Description | κ-Carrageenan is a natural polymer which predominantly available in red seaweeds. κ-Carrageenan is an effective drug carrier to deliver curcumin in cancer cells and to induce apoptosis. κ-carrageenan serves as a potential inflammatory agent that magnifies existing intestinal inflammation[1][2]. |
|---|---|
| Related Catalog | Research Areas >>CancerSignaling Pathways >>Others >>OthersResearch Areas >>Inflammation/Immunology |
| In Vitro | κ-Car- Curcumin (Cur) (0-500 μg/mL; 24-72 hours) effectively involves in cancer cell growth inhibition at lower concentrations of 40 µg/mL[1]. The cytotoxicity of the Cur loaded κ-Car has a significantly high apoptotic activity in selected lung cancer cells of A549[1]. κ-Carrageenan (1-60 μg/mL; 0.5-24 hours) enhances LPS-induced IL-8 secretion in HT-29 cells[2]. Cell Viability Assay[1] Cell Line: A549 cells Concentration: 0-500 μg/mL Incubation Time: 24, 48 and 72 hours Result: The dose response effects of cells treated with Cur loaded κ-Car after incubation of 24, 48 and 72 h exhibited a significant IC50 values of 65, 50 and 40 μg/mL respectively, for 24, 48, 72 h ours. |
| In Vivo | κ-Carrageenan (1.7-41.7 mg/kg; p.o. for 1 week prior to C. freundii DBS100 treatment) can synergistically activate LPS-induced inflammatory through the Bcl10-NF-κB pathway, as indicated by its aggravation of C. freundii DBS100-induced colitis in mice[2]. κ-Carrageenan enhances the C. freundii DBS100-dependent induction of TLR4 and NF-κB in the intestinal mucosa of infected mice[2]. κ-Carrageenan aggravated the TNBS-induced intestinal inflammation, and such an effect could be associated with the oxidative stress and activation of TLR4-NF-κB and MAPK/ERK1/2 pathway[3] Animal Model: Male and female NIH (s) mice[2] Dosage: 1.7 mg/kg, LOW; 8.3 mg/kg, MED; or 41.7 mg/kg, HIG Administration: Orally administered for 1 week prior to C. freundii DBS100 treatment Result: Enhanced the C. freundii DBS100-dependent induction of TLR4 and NF-κB in the intestinal mucosa of infected mice. |
| References | [1]. Sathuvan M, et al. κ-Carrageenan: An effective drug carrier to deliver curcumin in cancer cells and to induce apoptosis. Carbohydr Polym. 2017;160:184-193. [2]. Wu W, et al. κ-Carrageenan Enhances Lipopolysaccharide-Induced Interleukin-8 Secretion by Stimulating the Bcl10-NF-κB Pathway in HT-29 Cells and Aggravates C. freundii-Induced Inflammation in Mice. Mediators Inflamm. 2017;2017:8634865. [3]. Wei W, et al. Enhanced effect of κ-carrageenan on TNBS-induced inflammation in mice. Int Immunopharmacol. 2016;39:218-228. |
Chemical & Physical Properties
| Molecular Formula | C24H36O25S2-- |
|---|---|
| Molecular Weight | 788.65800 |
| Exact Mass | 788.09900 |
| PSA | 394.53000 |
| Appearance of Characters | Solid | White to almost white to yellow to brownish |
| InChIKey | ZNOZWUKQPJXOIG-UHFFFAOYSA-L |
| SMILES | O=S(=O)([O-])OC1C(CO)OC(OC2C3COC2C(O)C(OC2C(O)C(OC4C5COC4C(O)C(O)O5)OC(CO)C2OS(=O)(=O)[O-])O3)C(O)C1O |
| Water Solubility | H2O: 5 mg/mL hot, soluble |
Safety Information
| Hazard Codes | F+ |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
| RTECS | FI0704000 |
Articles5
More Articles| Layer-by-layer assembled cell instructive nanocoatings containing platelet lysate. Biomaterials 48 , 56-65, (2015) Great efforts have been made to introduce growth factors (GFs) onto 2D/3D constructs in order to control cell behavior. Platelet lysate (PL) presents itself as a cost-effective source of multiple GFs ... | |
| Self-assembled carrageenan/protamine polyelectrolyte nanoplexes-Investigation of critical parameters governing their formation and characteristics. Carbohydr. Polym. 123 , 339-49, (2015) The aim of this work was to investigate the feasibility of cross-linker free polyelectrolyte complex formation at the nanoscale between carrageenan (CAR) and protamine (PROT). The properties of CAR/PR... | |
| Immobilization of cells in carrageenan. Meth. Enzymol. 135 , 189, (1987) |
